Late Acute Liver Allograft Rejection; A Study of Its Natural History and Graft Survival in the Current Era
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
BACKGROUND: Late acute rejection (LAR) after liver transplantation is often associated with poor clinical outcomes. We reviewed our experience of managing LAR in the current era to determine its natural history. METHODS: A database of 970 consecutive adult liver transplants was reviewed retrospectively. LAR was defined as histologically proven acute cellular rejection occurring more than 90 days after transplantation. RESULTS: The incidence of LAR was 11%, with a mean time of 565 days (median, 311 days; range, 90-2922 days) after transplantation. The highest rates for LAR were in seronegative hepatitis (17%), primary biliary cirrhosis (16%), and primary sclerosing cholangitis (13%) with an odds ratio of 2.3, 2.1, and 1.8, respectively. Logistic regression showed that younger recipients, primary biliary cirrhosis, and previous graft loss were independent predictors of LAR (P<0.001). Mean trough whole blood tacrolimus levels were at their lowest levels 1 week before the diagnosis of rejection (5.5 ng/mL; SD, 2.6) compared with levels of 7.7 ng/mL 4 weeks before rejection, showing a clear temporal relation. Graft survival was worse in those with LAR (P<0.01), whereas the best graft survival was among early acute rejection cases (85% 10-year survival; P<0.01). Poor response to treatment correlated with the development of ductopenic rejection (r=0.3; P<0.01). Approximately half with early ductopenic rejection eventually died (n=15). CONCLUSION: LAR continues to provide a risk to patient and graft survival: understanding risk factors may allow an improvement in monitoring and early intervention and so prevent early graft loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We note that the number of AR subjects is small but reflects the ~20% prevalence of AR in LTR (26, 38–40).”
From The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells (2022) · cites this paper as [40]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 32 · Cited by 122
Metadata
- Authors
- Thurairajah, P. H., Carbone, M., Bridgestock, H., Thomas, P., Hebbar, S., Gunson, B. K., Shah, T., & Neuberger, J.
- Affiliations
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Corresponding author
- Thurairajah, Prem H.
- Neuberger, James
- Venue
- Transplantation
- Published
- 2013-04-15
- Volume
- 95
- Issue
- 7
- Pages
- 955-959
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2065282168
- Cited by
- 122
- References
- 32
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 8 · 2023: 17 · 2022: 18 · 2021: 11 · 2020: 11 · 2019: 8 · 2018: 7 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 6 · 2013: 3
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- late acute rejection, liver transplantation, graft survival, tacrolimus trough levels, primary biliary cirrhosis, primary sclerosing cholangitis, risk factors, graft loss, immunosuppression monitoring
- MeSH terms
- Acute Disease, Adult, Biopsy, England, Female, Graft Rejection, Graft Survival, Humans, Immunosuppressive Agents, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Incidence, Multivariate Analysis, Chi-Square Distribution, Logistic Models, Proportional Hazards Models, Odds Ratio, Liver Transplantation, Treatment Outcome, Risk Assessment, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Late Acute Liver Allograft Rejection; A Study of Its Natural History and Graft Survival in the Current Era. https://app.cochat.ai/papers/10.1097/tp.0b013e3182845f6c
- The paper
- Thurairajah, P. H., Carbone, M., Bridgestock, H., Thomas, P., Hebbar, S., Gunson, B. K., Shah, T., & Neuberger, J. (2013). Late Acute Liver Allograft Rejection; A Study of Its Natural History and Graft Survival in the Current Era. Transplantation. https://doi.org/10.1097/tp.0b013e3182845f6c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.